EPCAM and neoplasm: In our previous study directly focusing on the expression of putative stem cell markers in EMT-derived tumour cells, we describe a low frequency of CD44s, CD166, and EpCAM staining within tumour buds, thus emphasising the loss of cell adhesion molecules typical of these cells (Hostettler et al, 2010).